Analyst Reco. Silk Road Medical, Inc

Equities

SILK

US82710M1009

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
18.9 ^USD	+6.18%		+8.56%	+54.03%

Apr. 02	Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus	CI
Mar. 08	North American Morning Briefing : Stock Futures -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Argus Upgrades Silk Road Medical to Buy From Hold, Price Target is $24	Mar. 07	MT
Piper Sandler Raises Price Target on Silk Road Medical to $18 From $11, Maintains Neutral Rating	Feb. 29	MT
Stifel Upgrades Silk Road Medical to Buy From Hold, Raises Price Target to $20 From $9	Jan. 19	MT
Lake Street Initiates Silk Road Medical at Buy Rating With $20 Price Target	Jan. 03	MT
Oppenheimer Adjusts Silk Road Medical Price Target to $25 From $30, Maintains Outperform Rating	Nov. 09	MT
Wolfe Research Upgrades Silk Road Medical to Peer Perform From Underperform	23-10-24	MT
BofA Lowers Price Target on Silk Road Medical to $8 From $28, Keeps Underperform Rating	23-10-18	MT
Piper Sandler Lowers Price Target on Silk Road Medical to $11 From $25, Maintains Neutral Rating	23-10-11	MT
B. Riley Downgrades Silk Road Medical to Neutral From Buy, Lowers Price Target to $14 From $54	23-10-11	MT
CL King Downgrades Silk Road Medical to Neutral From Buy	23-10-11	MT
Nephron Research Downgrades Silk Road Medical to Hold From Buy, Adjusts Price Target to $10 From $37	23-10-11	MT
Citigroup Downgrades Silk Road Medical to Sell From Buy, Cuts Price Target to $8 From $35	23-10-11	MT
Stifel Downgrades Silk Road Medical to Hold From Buy, Cuts Price Target to $12 From $45	23-10-11	MT
Argus Research Downgrades Silk Road Medical to Hold From Buy	23-09-21	MT
Oppenheimer Initiates Coverage on Silk Road Medical With Outperform Rating, $30 Price Target	23-09-06	MT
Citigroup Cuts Price Target on Silk Road Medical to $35 From $48, Maintains Buy Rating	23-08-14	MT
Stifel Adjusts Price Target on Silk Road Medical to $45 From $50, Maintains Buy Rating	23-08-02	MT
B. Riley Lowers Silk Road Medical's PT to $54 From $58, Keeps Buy Rating	23-08-02	MT
BofA Securities Downgrades Silk Road Medical to Underperform From Buy, Adjusts Price Target to $28 From $51	23-07-12	MT
JPMorgan Downgrades Silk Road Medical to Neutral From Overweight, Cuts Price Target to $28 From $50	23-07-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Silk Road Medical, Inc

Equities

SILK

US82710M1009

Analyst Reco.

Filters